Author Search Results

Gamal Esmat

Gamal Esmat is a professor at Endemic Medicine and Hepatogastroenterology Department, Cairo University. He was vice president of Cairo University for Graduate Studies and Research.

Esmat has published scientific papers in journals on hepatitis, hepatocellular carcinoma and liver transplantation. Since 2001, he is the director of Clinical Research Unit, Hepatitis C Project, International Health Division, University of Maryland, Baltimore.

Esmat was the president of IASL (International Association for the Study of the Liver) during the period 2006 – 2008 and is recently the WHO consultant for management of viral hepatitis. Provided by Wikipedia

1

Hepatic and Intestinal Schistosomiasis: Review

by Tamer Elbaz, Gamal Esmat
Published 2013-09-01

Get full text

Article
2

Impact of dual hepatitis B and C infection on disease severity and treatment outcome: updated review

by Gamal Esmat, Tamer Elbaz
Published 2016-01-01

Get full text

Article
3

Human Schistosomiasis: Clinical Perspective: Review

by Rashad S. Barsoum, Gamal Esmat, Tamer El-Baz
Published 2013-09-01

Get full text

Article
4

New era for management of chronic hepatitis C virus using direct antiviral agents: A review

by Tamer Elbaz, Mohamed El-Kassas, Gamal Esmat
Published 2015-05-01

Get full text

Article
5

Antiretroviral therapy optimisation in the time of COVID-19: Is it really different in North and South Africa?

by Ahmed Cordie, Menna-t-allah El-Kotamy, Gamal Esmat
Published 2020-07-01

Get full text

Article
6

Impact of treating chronic hepatitis C infection with direct-acting antivirals on the risk of hepatocellular carcinoma: The debate continues – A mini-review

by Mohamed El Kassas, Tamer Elbaz, Mohamed Salaheldin, Lobna Abdelsalam, Ahmed Kaseb, Gamal Esmat
Published 2019-05-01

Get full text

Article
7

COVID-19 crisis effect on HIV service delivery in Egypt: Hard times or blessings in disguise?

by Rahma Mohamed, Heba Wanis, Sonia Zebachi, Menna-t-allah El-Kotamy, Gamal Esmat, Ahmed Cordie
Published 2020-12-01

Get full text

Article
8

Interferon therapy shifts natural killer subsets among egyptian patients with chronic hepatitis C

by Amal Fathy, Mohamed Mohy Eldin, Lobna Metwally, Mohamed Eida, Marwa Abdel-Rehim, Gamal Esmat

Get full text

Article
9

Interferon therapy shifts natural killer subsets among Egyptian patients with chronic hepatitis C

by Amal Fathy, Mohamed Mohy Eldin, Lobna Metwally, Mohamed Eida, Marwa Abdel-Rehim, Gamal Esmat
Published 2010-07-01

Get full text

Article
10

Noninvasive prediction of hepatitis C-associated hepatocellular carcinoma using circulating apolipoproteins

by Hasan El Garem, Gamal Esmat, Rabab Salama, Hanan Fouad, Dina Sabry, Yomna Mostafa, Dalia Omran, Heba Omar
Published 2019-01-01

Get full text

Article
11

Early diagnosis of esophageal varices using Boosted-Naïve Bayes Tree: A multicenter cross-sectional study on chronic hepatitis C patients

by Shimaa M. Abd-Elsalam, Mohamed M. Ezz, Shehab Gamalel-Din, Gamal Esmat, Ahmed Salama, Mahmoud ElHefnawi
Published 2020-01-01

Get full text

Article
12

Endoscopic band ligation combined with argon plasma coagulation versus band ligation alone for eradication of esophageal varices

by Ali Ghweil, Shamarden Bazeed, Mohamed Alsenbsy, Heba Saleh, Mohamed El Kassas, Bahaa Abbas, Gamal Esmat, Hamdy Moustafa
Published 2016-01-01

Get full text

Article
13

Liver fibrosis in young Egyptian beta-thalassemia major patients: relation to hepatitis C virus and compliance with chelation

by Mohsen S. Elalfy, MD, PhD, Gamal Esmat, Randa M. Matter, Hesham E. Abdel Aziz, Walid A. Massoud
Published 2013-01-01

Get full text

Article
14

Diffusion-weighted MRI and fibroscan vs. histopathology for assessment of liver fibrosis in chronic HCV patients: (Pilot study)

by Ahmed Hosni Kamel Abdelmaksoud, Maissa El-Raziky, Mohammad El-Sayed, Aisha Elsharkawy, Mohamed Karim Ashour, Hany Khattab, Gamal Esmat
Published 2015-06-01

Get full text

Article
15

Human Leukocyte Antigen Class II Alleles (DQB1 and DRB1) as Predictors for Response to Interferon Therapy in HCV Genotype 4

by Olfat Shaker, Heba Bassiony, Maissa El Raziky, Samer S. El-Kamary, Gamal Esmat, Akmal M. El-Ghor, Mona M. Mohamed
Published 2013-01-01

Get full text

Article
16

Egy-score as a noninvasive score for the assessment of hepatic fibrosis in chronic hepatitis C: A preliminary approach

by Mohamed Alboraie, Marwa Khairy, Aisha Elsharkawy, Marwa Elsharkawy, Noha Asem, Amany R. Abo El-Seoud, Fathy G. Elghamry, Gamal Esmat
Published 2014-01-01

Get full text

Article
17

Vitamin D Receptor FokI Gene Polymorphism Predicted Poor Response to Treatment in Chronic HCV Genotype 4

by Hany Shehab, Dina Sabry, Mai Mukhtar, Wafaa Elakel, Mahasen Mabrouk, Amr Zahra, Gamal Esmat, Amany Y El Kazaz, Amr Zahra
Published 2016-12-01

Get full text

Article
18

Health-related quality of life in Egyptian patients after liver transplantation

by Mahasen Mabrouk, Gamal Esmat, Ayman Yosry, Magdy El-Serafy, Wahid Doss, Naglaa Zayed, M.D., Medhat El-Sahhar, Sally Awny, Ashraf Omar
Published 2012-11-01

Get full text

Article
19

Accurate Prediction of Advanced Liver Fibrosis Using the Decision Tree Learning Algorithm in Chronic Hepatitis C Egyptian Patients

by Somaya Hashem, Gamal Esmat, Wafaa Elakel, Shahira Habashy, Safaa Abdel Raouf, Samar Darweesh, Mohamad Soliman, Mohamed Elhefnawi, Mohamed El-Adawy, Mahmoud ElHefnawi
Published 2016-01-01

Get full text

Article
20

Caspase recruitment domains. New potential markers for diagnosis of hepatocellular carcinoma associated with HCV in Egyptian patients

by Abdel-Rahman Zekri, Mohamed El-Kassas, Yasmin Saad, Abeer Bahnassy, Hany Khatab Sameh Seif El-Din, Samar K. Darweesh, Hanan Abdel Hafez, Gamal Esmat
Published 2013-09-01

Get full text

Article

1
2
Next
[2]